tiprankstipranks
Trending News
More News >
OncoZenge AB (DE:8LY)
:8LY
Germany Market

OncoZenge AB (8LY) Financial Statements

Compare
0 Followers

OncoZenge AB Financial Overview

OncoZenge AB's market cap is currently €4.64M. The company's EPS TTM is €-0.064; its P/E ratio is ―; OncoZenge AB is scheduled to report earnings on February 20, 2025, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenuekr 3.00Kkr 0.00kr 0.00kr 0.00
Gross Profitkr 3.00Kkr 0.00kr 0.00kr 0.00
Operating Incomekr -15.90Mkr -43.57Mkr -4.89Mkr -801.00K
EBITDAkr 7.27Mkr -43.57Mkr -4.89Mkr -801.00K
Net Incomekr -15.90Mkr -46.65Mkr -3.89Mkr -636.00K
Balance Sheet
Cash & Short-Term Investmentskr 12.63Mkr 29.14Mkr 51.22Mkr 10.00M
Total Assetskr 20.34Mkr 36.89Mkr 85.23Mkr 38.30M
Total Debtkr 0.00kr 0.00kr 0.00kr 0.00
Net Debtkr -12.63Mkr -29.14Mkr -51.22Mkr -10.00M
Total Liabilitieskr 1.70Mkr 2.92Mkr 4.90Mkr 9.01M
Stockholders' Equitykr 18.64Mkr 33.97Mkr 80.32Mkr 29.28M
Cash Flow
Free Cash Flowkr -17.08Mkr -22.08Mkr -10.12Mkr -1.00K
Operating Cash Flowkr -17.08Mkr -22.08Mkr -4.77Mkr -1.00K
Investing Cash Flowkr 570.00Kkr 0.00kr -5.36Mkr 0.00
Financing Cash Flowkr 0.00kr 0.00kr 51.34Mkr 10.00M
Currency in SEK

OncoZenge AB Earnings and Revenue History

OncoZenge AB Debt to Assets

OncoZenge AB Cash Flow

OncoZenge AB Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis